Brian Gormley

1 week ago | createsend.com | Brian Gormley

Good day. The global trade war has jolted financing markets, forcing many startups to consider alternatives to venture capital and initial public offerings. Haim Zaltzman, global vice chair of the emerging companies and growth practice of law firm Latham & Watkins, has been advising entrepreneurs as they navigate the turbulence. We spoke about financing alternatives with Zaltzman, whose practice includes work with biotech and medical-device startups, and venture and debt investors in these sectors.

1 week ago | createsend.com | Brian Gormley

Good day. Digital-health startups can capitalize on uncertain times to make big leaps if they are willing to take risks on creative business models and strategies, according to an analysis by Rock Health. The conventional playbook of raising rounds of venture capital until a company is acquired or goes public isn’t always the best approach for startups innovating in areas such as healthcare artificial intelligence or virtual care.

1 week ago | wsj.com | Brian Gormley

Turbulence in the capital markets is driving biotechnology startups and venture capitalists to consider strategies such as forming closer ties to large pharmaceutical companies. With optimism budding early this year, biotechs raised $6.3 billion in venture capital in the first quarter, a faster pace than in 2024, when these companies collected $23.6 billion for the full year, according to investment bank William Blair. Biotechs raised $5.4 billion in the first quarter of 2024.

3 weeks ago | wsj.com | Brian Gormley

New investors Menlo Ventures, SignalFire back startup as insurance coverage for patient advocacy expandsApril 3, 2025 6:00 am ET|WSJ ProSolace has raised $60 million in new venture financing, double what it originally sought, as insurance coverage for the healthtech startup’s patient-advocacy services has expanded.

3 weeks ago | wsj.com | Brian Gormley |Marc Vartabedian

CoreWeave’s bumpy takeoff as well as market volatility are deterring startups from going public. Still, some investors continue to warm hopes for a rebound this year. April 2, 2025 5:30 am ET|WSJ ProCoreWeave’s initial public offering last week has thrown venture capitalists’ plans to take startups public this year into further doubt. Early this year, investors and entrepreneurs were optimistic that IPOs would snap out of the sluggishness that had hampered them for years.